FDA regulatory hurdles are delaying the import of European products into the US market.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA regulatory hurdles are delaying the import of European products into the US market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A 2019 finding indicated that the US regulatory process was slower than European standards.Sub-event
US FDA approval processes are restricting market access for European products.1 source
Keep exploring
The entities involved
Related events
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.
- Trinity Biotech announced that its Premier Hb9210™ analyser received FDA clearance and the company plans to accelerate growth across its diagnostics franchise in Europe.
- FDA regulates drug shortages and systemic supply chain issues in the US.
- Industry trends are influenced by regulatory body requests, according to a recent report involving RTI International.